133 related articles for article (PubMed ID: 23250778)
1. Increased expression of CD24 in nonmelanoma skin cancer.
Miller E; Shapira S; Gur E; Naumov I; Kazanov D; Leshem D; Barnea Y; Meshiach Y; Gat A; Sion D; Arber N; Kraus S
Int J Biol Markers; 2012 Dec; 27(4):e331-6. PubMed ID: 23250778
[TBL] [Abstract][Full Text] [Related]
2. High serum 25-hydroxyvitamin D concentration in patients with a recent diagnosis of non-melanoma skin cancer: a case-control study.
Soares AM; Szejnfeld VL; Enokihara MY; Michalany N; Castro CH
Eur J Dermatol; 2018 Oct; 28(5):649-653. PubMed ID: 30355545
[TBL] [Abstract][Full Text] [Related]
3. A pilot study of chromosomal aberrations and epigenetic changes in peripheral blood samples to identify patients with melanoma.
Jakub JW; Grotz TE; Jordan P; Hunter E; Pittelkow M; Ramadass A; Akoulitchev A; Markovic S
Melanoma Res; 2015 Oct; 25(5):406-11. PubMed ID: 26225582
[TBL] [Abstract][Full Text] [Related]
4. An expression of squamous cell carcinoma antigen 2 in peripheral blood within the different stages of esophageal carcinogenesis.
Yang YF; Li H; Xu XQ; Diao YT; Fang XQ; Wang Y; Zhao DL; Wu K; Li HQ
Dis Esophagus; 2008; 21(5):395-401. PubMed ID: 19125792
[TBL] [Abstract][Full Text] [Related]
5. Divergence between the high rate of p53 mutations in skin carcinomas and the low prevalence of anti-p53 antibodies.
Moch C; Moysan A; Lubin R; de la Salmonière P; Soufir N; Galisson F; Vilmer C; Venutolo E; Le Pelletier F; Janin A; Basset-Séguin N
Br J Cancer; 2001 Dec; 85(12):1883-6. PubMed ID: 11747330
[TBL] [Abstract][Full Text] [Related]
6. L-myc polymorphism in head and neck nonmelanoma skin and lower lip cancers.
Gözü A; Ergen A; Dayicioglu D; Yaylim I; Ozsoy Z; Isbir T
Arch Otolaryngol Head Neck Surg; 2008 Jul; 134(7):725-8. PubMed ID: 18645122
[TBL] [Abstract][Full Text] [Related]
7. Delayed treatment and continued growth of nonmelanoma skin cancer.
Alam M; Goldberg LH; Silapunt S; Gardner ES; Strom SS; Rademaker AW; Margolis DJ
J Am Acad Dermatol; 2011 May; 64(5):839-48. PubMed ID: 21055843
[TBL] [Abstract][Full Text] [Related]
8. microRNA profiling for early detection of nonmelanoma skin cancer.
Balci S; Ayaz L; Gorur A; Yildirim Yaroglu H; Akbayir S; Dogruer Unal N; Bulut B; Tursen U; Tamer L
Clin Exp Dermatol; 2016 Jun; 41(4):346-51. PubMed ID: 26299703
[TBL] [Abstract][Full Text] [Related]
9. Diagnosis of nonmelanoma skin cancer/keratinocyte carcinoma: a review of diagnostic accuracy of nonmelanoma skin cancer diagnostic tests and technologies.
Mogensen M; Jemec GB
Dermatol Surg; 2007 Oct; 33(10):1158-74. PubMed ID: 17903149
[TBL] [Abstract][Full Text] [Related]
10. Frozen section diagnosis for non-melanoma skin cancers: correlation with permanent section diagnosis.
Onajin O; Wetter DA; Roenigk RK; Gibson LE; Weaver AL; Comfere NI
J Cutan Pathol; 2015 Jul; 42(7):459-64. PubMed ID: 25924858
[TBL] [Abstract][Full Text] [Related]
11. Nonmelanoma skin cancer mortality (1988-2000): the Rhode Island follow-back study.
Lewis KG; Weinstock MA
Arch Dermatol; 2004 Jul; 140(7):837-42. PubMed ID: 15262694
[TBL] [Abstract][Full Text] [Related]
12. CD24 gene polymorphism--a novel prognostic factor in esophageal cancer.
Sadot E; Kraus S; Stein M; Naboishchikov I; Toledano O; Kazanov D; Arber N; Kashtan H
Int J Biol Markers; 2014 Mar; 29(1):e49-54. PubMed ID: 24474454
[TBL] [Abstract][Full Text] [Related]
13. Nonmelanoma skin cancer and risk for subsequent malignancy.
Chen J; Ruczinski I; Jorgensen TJ; Yenokyan G; Yao Y; Alani R; Liégeois NJ; Hoffman SC; Hoffman-Bolton J; Strickland PT; Helzlsouer KJ; Alberg AJ
J Natl Cancer Inst; 2008 Sep; 100(17):1215-22. PubMed ID: 18728282
[TBL] [Abstract][Full Text] [Related]
14. Immunohistochemical expression of sperm-associated antigen 9 in nonmelanoma skin cancer.
Seleit I; Bakry OA; Samaka RM; Malak MA
Am J Dermatopathol; 2015 Jan; 37(1):38-45. PubMed ID: 25033008
[TBL] [Abstract][Full Text] [Related]
15. XPD polymorphism and risk of subsequent cancer in individuals with nonmelanoma skin cancer.
Brewster AM; Alberg AJ; Strickland PT; Hoffman SC; Helzlsouer K
Cancer Epidemiol Biomarkers Prev; 2004 Aug; 13(8):1271-5. PubMed ID: 15298945
[TBL] [Abstract][Full Text] [Related]
16. Patient perceptions of nonmelanoma skin cancer before diagnosis.
Yancovitz M; Rizzo C; Julian P; Oliveria SA; Becker D
Dermatol Surg; 2013 Oct; 39(10):1496-501. PubMed ID: 24090260
[TBL] [Abstract][Full Text] [Related]
17. A prospective comparison of spectrophotometric intracutaneous analysis to clinical judgment in the diagnosis of nonmelanoma skin cancer.
Tehrani H; Walls J; Price G; Cotton S; Sassoon EM; Hall PN
Ann Plast Surg; 2007 Feb; 58(2):209-11. PubMed ID: 17245151
[TBL] [Abstract][Full Text] [Related]
18. The accuracy of clinical diagnosis of suspected premalignant and malignant skin lesions in renal transplant recipients.
Cooper SM; Wojnarowska F
Clin Exp Dermatol; 2002 Sep; 27(6):436-8. PubMed ID: 12372077
[TBL] [Abstract][Full Text] [Related]
19. Characteristics and outcomes of nonmelanoma skin cancer (NMSC) in children and young adults.
Khosravi H; Schmidt B; Huang JT
J Am Acad Dermatol; 2015 Nov; 73(5):785-90. PubMed ID: 26323552
[TBL] [Abstract][Full Text] [Related]
20. No association between telomere length in peripheral blood leukocytes and the risk of nonmelanoma skin cancer.
Liang G; Qureshi AA; Guo Q; De Vivo I; Han J
Cancer Epidemiol Biomarkers Prev; 2011 May; 20(5):1043-5. PubMed ID: 21357377
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
